Skip to main content
SpringerLink
Log in

Pathology of Renal Cell Carcinoma: Correlation of Morphology, Immunophenotype, and Genetic and Clinical Aspects

  • Chapter
Renal Cell Cancer

  • 1113 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gilbert JB.: Diagnosis and treatment of malignant renal tumors. J. Urol. 1938; 39: 223–237.

    Google Scholar 

  2. Grawitz PA.: Die Entstehung von Nierentumoren aus Nebennierengewebe. Arch. Klin. Chir. 1884; 30: 824–834.

    Google Scholar 

  3. Sudeck P.: Ueber die Strucktur der Nieradenoma. Ihre Stellung zu den Strumae suprarenales aberrante (Grawitz). Arch. Pathol. Anat. Pysiol. Klin. Med. 1893; 133: 405–409.

    Article  Google Scholar 

  4. Delahunt B, Thornton A.: Renal cell carcinoma. A historical perspective. J. Urol. Pathol. 1996; 4: 31–49.

    Google Scholar 

  5. O’Crowley CR, Martland.: Adrenal heterotopia, rests, and the so-called Grawitz tumor. J. Urol. 1943; 50: 756–768.

    Google Scholar 

  6. Herbut PA.: Urological Pathology. Vol. I, p. 608. Lea & Febiger, Philadelphia, 1952.

    Google Scholar 

  7. Oberling C, Rivière M, Haguenan F.: Ultrastructure of the clear cells in renal carcinomas and its importance for the determination of their renal origin. Nature. 1960; 186: 402–403.

    Article  PubMed  CAS  Google Scholar 

  8. Bennington JL, Beckwith JB.: Tumors of the kidney, renal pelvis, and ureter. Atlas of tumor pathology. Second series. Fascicle 12 p. 130. AFIP Washington, 1975.

    Google Scholar 

  9. Thoenes W, Störtkel S, Rumpelt HJ.: Human chromophobe cell renal carcinoma. Wirchows Arch. (Cell Pathol.) 1985; 155: 277–287.

    Google Scholar 

  10. Störkel S, Pannen B, Thoenes W, Staert PV, Wagner S, Drenckhalm D.: Intercalated cells as a probable source for the development of renal oncocitoma.. Wirchows Arch. (B) 1988; 56: 185–189.

    Google Scholar 

  11. Liu GF, Song-Liang C, Bi-Juan C, Chieh-Ping W.: Cellular origin of renal cell carcinoma. An immunohistochemical study on monoclonal antibodies. Scand. J. Urol. Nephrol. 1991; 138 (S): 203–206.

    Google Scholar 

  12. Kovacs G.: Molecular differential pathology of renal cell tumours. Histopathology 1993; 22: 1–8.

    Article  PubMed  CAS  Google Scholar 

  13. Kovacs G, Akhtar M, Beckwith BJ.: The Heidelberg classification of renal cell tumours. J. Pathol. 1997; 183: 131–133.

    Article  PubMed  CAS  Google Scholar 

  14. Eble JN, Sauter G, Epstein JI, Sesterhenn IA.: World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 10. IARC Press, Lyon, 2004.

    Google Scholar 

  15. Algaba F, Trias I, Scarpelli M, Boccon-Gibod L, Kirkali Z, Van Poppel H.: Handling and pathology reporting of renal tumor specimens. Eur. Urol. 2004; 45: 437–443.

    Article  PubMed  CAS  Google Scholar 

  16. Fleming S, Griffiths DFR.: Nephrectomy for renal tumour; dissection guide and dataset. J. Clin. Pathol. 2005; 58: 7–14.

    Article  PubMed  CAS  Google Scholar 

  17. Algaba F, Arce Y, Lopez-Beltran A, Montironi R, Mikuz G, Bono AV; European Society of Uropathology; Uropathology Working Group.: Intraoperative frozen section diagnosis in urological oncology. Eur. Urol. 2005; 47: 129–136.

    Article  PubMed  CAS  Google Scholar 

  18. Sobin LH, Wittekind CH.: Urological tumours. In: Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. Geneva UICC, 2002: 179–206.

    Google Scholar 

  19. Ficarra V, Prayer-Galetti T, Novara G, Bratti E, Zanolla L, dak Bianco M, Artibani W, Pagano F.: Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma. Urology 2004; 63: 235–240.

    Article  PubMed  Google Scholar 

  20. Wunderlich H, Dreihaup M, Schlichter A, Kosmehl H, Reichelt O, Schubert J.: New cut-off point between T1 and T2 renal cell carcinoma—-Necessary for a better discriminatory power of the TNM classification. Urol. Int 2004; 72: 123–128.

    Article  PubMed  CAS  Google Scholar 

  21. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Kwon ED, Zincke H.: pT2 classification for renal cell carcinoma. Can its accuracy be improved?. J. Urol. 2005; 173: 380–384.

    Article  PubMed  Google Scholar 

  22. Ficarra V, Guille F, Schips L, de la Taille A, Prayer Galetti T, Tostain J, Cindolo L, Novara G, Zigeuner R, Bratti E, Li G, Altieri V, Abbou CC, Zanolla L, Artibani W, Patard JJ.: Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer. 2005; 104: 2116–2123.

    Google Scholar 

  23. Patard JJ, Shvarts O, Lam JS, Pantuck AJ, K8im HL, Ficarra V, Cindolo L, Han KR, De la Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Mulders PF, Belldegrun AS.: Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J. Urol. 2004; 171: 2181–2185

    Google Scholar 

  24. Murphy AM, Gilbert SM, Katz AE, Goluboff ET, Sawczuk IS, Olsson CA, Benson MC, McKiernan JM.: Re-evaluation of the tumour-node-metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a). BJU Int. 2005; 95: 27–30.

    Article  PubMed  Google Scholar 

  25. Siemer S, Lehmann J, Loch A, Becker F, Stein U, Schneider G, Ziegler M, StockleM.: Current TNM classification of renal cell carcinoma evaluated: revising stageT3a. J. Urol. 2005; 173: 33–37.

    PubMed  CAS  Google Scholar 

  26. Bonsib SM.: The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. Am. J. Surg. Pathol. 2004; 28: 1594–1600.

    Article  PubMed  Google Scholar 

  27. Bonsib SM, Gibson D, Mhoon M, Greene GF.: Renal sinus involvement in renal cell carcinoma. Am. J. Surg. Pathol. 2000; 24: 451–458.

    Article  PubMed  CAS  Google Scholar 

  28. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS.: Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J. Urol. 2005; 173: 1853–1862.

    Article  PubMed  Google Scholar 

  29. Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED, Frank I, Blute ML, Leibovich BC.: Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer 2005; 104: 53–60.

    Article  PubMed  Google Scholar 

  30. Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS.: Renal cell carcinoma with tumor thrombus extension: biological role of nephrectomy and response to immunotherapy. J. Urol. 2003; 169: 909–916.

    Article  PubMed  Google Scholar 

  31. Moinzadeh A, Libertino JA.: Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J. Urol. 2004; 171: 598–601.

    Article  PubMed  Google Scholar 

  32. Palapattu GS, Pantuck AJ, Dorey F.: Collecting system invasion in renal cell carcinoma impact on prognosis and future staging strategies. J. Urol. 2003; 170: 768–772.

    Article  PubMed  Google Scholar 

  33. Terrone C, Cracco C, Guercio S, Bollito E, Poggio M, Scoffone C, Tarabuzzi R, Porpiglia F, Scarpa RM, Fontana D, Rocca Rossetti S.: Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma. Eur. Urol. 2004; 46: 472–476.

    Article  PubMed  CAS  Google Scholar 

  34. Terrone C, Guercio S, De Luca S, Poggio M, Castelli E, Scoffone C, Tarabuzzi R, Scarpa RM, Fontana D, Roca Rossetti S.: The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int. 2003; 91: 37–40.

    Article  PubMed  CAS  Google Scholar 

  35. Fuhrman SA, Lasky LC, Limas C.: Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982; 6: 655–663.

    PubMed  CAS  Google Scholar 

  36. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.: Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 2000; 163: 1090–1095.

    Article  PubMed  CAS  Google Scholar 

  37. Algaba F.: Prognostic factors of epithelial tumours of the kidney. Pathologica 1999; 91: 51–53.

    PubMed  CAS  Google Scholar 

  38. Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L.: Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch. Pathol. Lab. Med. 2003; 127: 593–596.

    PubMed  Google Scholar 

  39. Bos SD, Mellema CT, Mensink HJ.: Increase in incidental renal cell carcinoma in the northern part of the Netherlands. Eur. Urol. 2000; 37: 267–270.

    Article  PubMed  CAS  Google Scholar 

  40. Gelb AB, Shibuya RB, Weiss LM, Medeiros LJ.: Stage I renal cell carcinoma. A clinicopathologic study of 82 cases. Am. J. Surg. Pathol. 1993; 17: 275–286.

    Article  PubMed  CAS  Google Scholar 

  41. Paner GP, Alvarado-Cabrero I, Moch H, Young A, Stricker H, Lyles R, Datta MW, Amin MB.: A novel nuclear grading scheme for chromophobe renal cell carcinoma. Prognostic utility and comparison with Fuhrman’s nuclear grading. Mod. Pathol. 2006; 19: 154 (711).

    Google Scholar 

  42. Van Poppel H, Vandendriessche H, Boel K, Mertens V, Goethuys H, Haustermans K, Van Damme B, Baert L.: Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically non-metastatic renal cell carcinoma. J. Urol. 1997; 158: 45–49.

    Article  PubMed  Google Scholar 

  43. Sevinc M, Kirkali Z, Yorukoglu K, Mungan U, Sade M.: Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur. Urol. 2000; 38: 728–733.

    Article  PubMed  CAS  Google Scholar 

  44. Lang H, Lindner V, Saussine C, Havel D, Faure F, Jacqmin D.: Microscopic venous invasion: a prognostic factor in renal cell carcinoma. Eur. Urol. 2000; 38: 600–605.

    Article  PubMed  CAS  Google Scholar 

  45. Lang H, Lindner V, Letourneux H, Martin M, Saussine C, Jacqmin D.: Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up. Eur. Urol. 2004; 46: 331–335.

    Article  PubMed  Google Scholar 

  46. Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.: Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer 2005; 103: 2517–2525.

    Article  PubMed  CAS  Google Scholar 

  47. Hemmerlein B, Kugler A, Ozisik R, Ringert RH, Radzun HJ, Thelen P.: Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch. 2001; 439: 645–652.

    PubMed  CAS  Google Scholar 

  48. Algaba F.: Is tumor necrosis a predictor of survival in patients with renal cell carcinoma? Nat. Clin. Pract. Urol. 2006; 3: 196–197.

    Article  Google Scholar 

  49. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, De-Peralta Venturina M, Deshpande A, Menon M.: Prognostic impact of histologic subtyping of adult renal epithelial neoplasms. An experience of 405 cases. Am. J. Surg. Pathol. 2002; 26: 281–291.

    Google Scholar 

  50. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML.: Comparisons of outcome and prognostic features among histological subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 2003; 27: 612–624.

    Article  PubMed  Google Scholar 

  51. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, de la Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guille F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Patuck AJ.: Prognostic value of histologic subtypes in renal cell carcinomas: a multicenter experience. J. Clin. Oncol. 2005; 23: 2763–2771.

    Article  PubMed  Google Scholar 

  52. Renshaw AA, Richie JP.: Subtypes of renal carcinoma. Different onset and sites of metastatic disease. Am. J. Clin. Pathol. 1999; 111: 539–549.

    PubMed  CAS  Google Scholar 

  53. Motzer RJ, Bacik J, Mariani T , Russo P, Mazumdar M, Reuter V.: Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J. Clin. Oncol. 2002; 20: 2376–2381.

    Article  PubMed  Google Scholar 

  54. Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.: Understanding familial and non-familial renal cell cancer. Hum. Mol. Genet. 2002; 11: 2489–2498.

    Article  PubMed  CAS  Google Scholar 

  55. Fleming S, O’Donell M.: Surgical pathology of renal epithelial neoplasms: recent advances and current status. Histopathology 2000; 36: 195–202.

    Article  PubMed  CAS  Google Scholar 

  56. Eble JN.: Multilocular cystic renal cell carcinoma. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 26. IARC Press, Lyon, 2004.

    Google Scholar 

  57. Suzigan S, Lopez-Beltran A, Montironi R, Drut R, Romero A, Hayashi T, Gentili AL, Fonseca PS, deTorres I, Billis A, Japp LC, Bollito E, Algaba F, Requena-Tapias MJ.: Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am. J. Clin. Pathol. 2006; 125: 217–222.

    Article  PubMed  Google Scholar 

  58. Füzesi L, Gunawan B, Bergmann F, Tack S, Braun S, Jakse G.: Papillary renal cell carcinoma with clear cytomorphology and chromosomal loss of 3p. Histopathology 1999; 35: 157–161.

    Article  PubMed  Google Scholar 

  59. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, Blute ML.: Sarcomatoid renal cell carcinoma. An examination of underlying histologic subtype and analysis of associations with patient outcome. Am. J. Surg. Pathol. 2004; 28: 435–441.

    Article  PubMed  Google Scholar 

  60. Chu PG, Weiss LM.: Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases. Histopathology 2001; 39: 455–462.

    Article  PubMed  CAS  Google Scholar 

  61. Young AN, de Oliveira Sales PG, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS, Amin MB.: Beta-defensin-1, parvalbumin and vimentin. A panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am. J. Surg. Pathol. 2003; 27: 199–205.

    Google Scholar 

  62. Avery AK, Beckstead J, Renshaw AA, Corless CL.: Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000; 24: 203–210.

    Article  PubMed  CAS  Google Scholar 

  63. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R.: Expression of MUC1(EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Modern Pathol. 2004; 17: 180–188.

    Article  CAS  Google Scholar 

  64. Chuang ST, Chu P, Sugimura J, Tretiakova MS, Papavero V, Wang K, Tan MH, Lin F, The BT, Yang XJ.: Overexpression of glutathione S-transferase α in clear cell renal cell carcinoma. Am. J. Clin. Pathol. 2005; 123: 421–429.

    Article  PubMed  CAS  Google Scholar 

  65. Mazal PR, Exner M, Haitel A, Krieger S, Thomson RB, Aronson PS, Susani M.: Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum. Pathol. 2005; 36: 22–28.

    Article  PubMed  CAS  Google Scholar 

  66. Petit A, Castillo M, Santos M, Mellado B, Alcover J, Mallofrè C.: Kit expression in chromophobe cell carcinoma. Comparative immunohistochemical analysis of kit expression in different renal cell neoplasms. Am. J. Surg. Pathol. 2004; 28: 676–678.

    PubMed  Google Scholar 

  67. Patton KT, Tretiakova MS, Yao JL, Papavero V, Huo L, Adley BP, Wu G, Huang J, Pins MR, Teh BT, Yang XJ.: Expression of RON-proto-oncogene in renal oncocytoma and chromophobe renal cell carcinoma. Am. J. Surg. Pathol. 2004; 28: 1045–1050.

    Article  PubMed  Google Scholar 

  68. Tretiakova MS, Sahoo S, Takahashin M, Turkyilmaz M, Vogelzang NJ, Lin F, Krausz T, Teh BT, Yang XJ.: Expression of alpha-methylacil-CoA racemase in papillary renal cell carcinoma. Am. J. Surg. Pathol. 2004; 28: 69–76.

    Article  PubMed  Google Scholar 

  69. Velickovic M, Delahunt B, Grebe SKG.: Loss of heterozygosity at 3p14.2 in clear cell carcinoma is an early event and is localized to the FHIT gene locus. Cancer Res. 1999; 59: 1323–1326.

    PubMed  CAS  Google Scholar 

  70. Velickovic M, Delahunt B, Störkel S, Grebe SKG.: VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. Cancer Res. 2001; 61: 4815–4819.

    PubMed  CAS  Google Scholar 

  71. Schraml P, Struckmann K, Hatz F, Sonnet S, Kully C, Gasser T, Sauter G, Mihatsch MJ, Moch H.: VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J. Pathol. 2002; 196; 186–193.

    Google Scholar 

  72. Morrisey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.: Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear and papillary renal cell carcinoma. Cancer Res. 2001; 61: 7277–7281.

    Google Scholar 

  73. Lott ST, Lovell M, Naylor SL, Killary AM.: Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12. Cancer Res. 1998; 58: 3533–3537.

    PubMed  CAS  Google Scholar 

  74. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS.: Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J. Urol. 2005; 173: 1853–1862.

    Article  PubMed  Google Scholar 

  75. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D.: Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 2003; 111:1287–1295.

    PubMed  CAS  Google Scholar 

  76. Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI.: Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 2006; 24: 16–24.

    Article  PubMed  CAS  Google Scholar 

  77. Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV.: Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur. Urol. 2005; 48: 593–600.

    Article  PubMed  Google Scholar 

  78. Chow GK, Myles J, Novick AC.: The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation. Can. J. Urol. 2001; 8: 1223–1228.

    PubMed  CAS  Google Scholar 

  79. Thoenes W, Storkel S, Rumpelt HJ.: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract. 1986; 181: 125–143.

    PubMed  CAS  Google Scholar 

  80. Delahunt B, Eble JN.: Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod. Pathol. 1997; 10: 537–544.

    PubMed  CAS  Google Scholar 

  81. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.: Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am. J. Surg. Pathol. 1997; 21: 621–635.

    Article  PubMed  CAS  Google Scholar 

  82. Renshaw AA, Zhang H, Corless CL, Fletcher JA, Pins MR.: Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am. J. Surg. Pathol. 1997; 21: 1203–1209.

    Article  PubMed  CAS  Google Scholar 

  83. Delahunt B, Eble JN.: Papillary renal cell carcinoma. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 27. IARC Press, Lyon, 2004.

    Google Scholar 

  84. Martignoni G, Pea M, Brunelli M, Chilosi M, Zamò A, Bertaso M, Cossu-Rocca P, Eble JN, Mikuz G, Puppa G, Badonal C, Ficarra V, Novella G, Bonetti F.: CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod. Pathol. 2004; 17: 1455–1463.

    Article  PubMed  CAS  Google Scholar 

  85. Leroy X, Zini L, Leteurtre E, Zerimech F, Porchet N, Aubert JP, Gosselin B, Copin MC.: Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod. Pathol. 2002; 15: 1126–1130.

    Article  PubMed  Google Scholar 

  86. Went P, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch H.: Expression of epithelial cell adhesion molecule (EpCAM) in renal epithelial tumors. Am. J. Surg. Pathol. 2005; 29: 83–88.

    Article  PubMed  Google Scholar 

  87. Zhou M, Roma A, Magi-Galluzzi C.: The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin. Lab. Med. 2005; 25: 247–257.

    Article  PubMed  Google Scholar 

  88. Paner GP, Srigley JR, Radhakrishnan A, Cohen C, Skinnider BF, Tickoo SK,Young AN, Amin MB.: Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am. J. Surg. Pathol. 2006; 30: 13–19.

    Google Scholar 

  89. Kovacs G, Fucesi L, Emanual A, Kung HF.: Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 1991; 3: 249–255.

    Article  PubMed  CAS  Google Scholar 

  90. Schmidt L, Junker K, Weirich G, Glenn G, Choyke P, Lubensky I, Zhuang Z, Jeffers M, Vande Woude G, Neumann H, Walther M, Linehan WM, Zbar B.: Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res. 1998; 58(8): 1719–1722.

    Google Scholar 

  91. Sanders ME, Mick R, Tomaszewski JE, Barr FG.: Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am. J. Pathol. 2002; 161: 997–1005.

    PubMed  Google Scholar 

  92. Renshaw AA.: Subclassification of renal neoplasms: an update for practicing pathologists. Histopathology 2002; 41: 283–300.

    Article  PubMed  CAS  Google Scholar 

  93. Störkel S, Steart PV, Drenckhahn D, Thoenes W.: The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol. 1989; 56: 237–245.

    Article  PubMed  Google Scholar 

  94. Thoenes W, Störkel S, Rumpelt H-J, Moll R, Baum HP, Werner S.: Chromophobe cell renal carcinoma and its variants—-a report on 32 cases. J. Pathol. 1988; 155: 277–287.

    Article  PubMed  CAS  Google Scholar 

  95. Akhtar M, Kardar H, Linjawi T, McClintock J, Ali MA.: Chromophobe cell carcinoma of the kidney: a clinicopathologic study of 21 cases. Am. J. Surg. Pathol. 1995; 19:1245–1256.

    PubMed  CAS  Google Scholar 

  96. Latham B, Dickersin GR, Oliva E.: Subtypes of chromophobe cell renal carcinoma. An ultrastructural and histochemical study of 13 cases. Am. J. Surg. Pathol. 1999; 23:530–535.

    Article  PubMed  CAS  Google Scholar 

  97. Störkel S, Martignoni G, van den Berg E.: Chromophobe renal cell carcinoma In Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 30. IARC Press, Lyon, 2004.

    Google Scholar 

  98. Bonsib SM.: Renal chromophobe cell carcinoma. The relationship between cytoplasmic vesicles and colloidal iron stain. J. Urol. Pathol. 1996; 4: 9–14.

    Google Scholar 

  99. DeLong WH, Sakr W, Grignon DJ.: Chromophobe renal cell carcinoma. A comparative histochemical and immunohistochemical study. J. Urol. Pathol. 1996; 4: 1–8.

    Google Scholar 

  100. Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH.: Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod. Pathol. 2002; 15: 712–717.

    Article  PubMed  Google Scholar 

  101. Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, Schumaker B, Tickoo SK.: Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004; 45: 595–602.

    Article  Google Scholar 

  102. McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, Ro JY, Lechago J, Truong LD.: Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody ‘Renal Cell Carcinoma Marker.’ Am. J. Surg. Pathol. 2001; 25: 1485–1492.

    Article  PubMed  CAS  Google Scholar 

  103. Speicher MR, Schoell B, du Manoir S, Schrock E, Ried T, Cremer T, Störkel S, Kovacs G.: Specific loss of chromosomes 1, 2, 6, 10, 13, 17 and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am. J. Pathol. 1994; 145: 356–364.

    PubMed  CAS  Google Scholar 

  104. Roth JS, Rabinowitz AD, Benson M, Grossman ME.: Bilateral renal cell carcinoma in the Birt-Hogg-Dubè syndrome Am. Acad. Dermatol. 1993; 6: 1055–1056.

    Article  Google Scholar 

  105. Contractor H, Zariwala M, Bugert P, Zeisler J, Kovacs G.: Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour. J. Pathol. 1997; 181: 136–139.

    Article  PubMed  CAS  Google Scholar 

  106. Sukosd F, Digon B, Fischer J, Pietsch T, Kovacs G.: Allelic loss at 10q23.3, but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma. Cancer Genet. Cytogenet. 2001; 128: 161–163.

    Article  PubMed  CAS  Google Scholar 

  107. Orsola A, Trias I, Raventòs CX, Español I, Cecchini L, Orsola I.: Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma. Urology 2005; 65: 49–54.

    Article  PubMed  CAS  Google Scholar 

  108. Kafe H, Verbavatz JM, Cochand-Priollet B, Castagnet P, Viellefond J.: Collecting duct carcinoma: an entity to be redefined? Virchows Arch. 2004; 445: 637–640.

    Article  PubMed  Google Scholar 

  109. Srigley JR, Moch H.: Carcinoma of the collecting ducts of Bellini. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 33. IARC Press, Lyon, 2004.

    Google Scholar 

  110. Srigley JR, Eble JN.: Collecting duct carcinoma of kidney. Sem. Diagn. Pathol. 1998; 15: 54–57.

    CAS  Google Scholar 

  111. Kennedy SM, Merino M, Linehan WM, Roberts JR, Robertson CN, Neumann RD.: Collecting duct carcinoma of the kidney. Hum. Pathol. 1990; 21: 449–456.

    Article  PubMed  CAS  Google Scholar 

  112. De Peralta-Venturina M, Moch H, Amin M, Tamboli O, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB.: Sarcomatoid differentiation in renal cell carcinoma. A study of 101 cases. Am. J. Surg. Pathol. 2001; 25: 275–284.

    Article  PubMed  Google Scholar 

  113. Fleming S, Symes CE.: The distribution of cytokeratin antigens in the kidney and in renal tumours. Histopathology 1987; 11: 157–170.

    Article  PubMed  CAS  Google Scholar 

  114. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M.: Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod. Pathol. 2005; 18: 535–540.

    Article  PubMed  CAS  Google Scholar 

  115. Pan CC, Chen PC, Ho DM.: The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 2004; 45: 452–459.

    Article  PubMed  Google Scholar 

  116. Füzesi L, Cober M, Mittermayer CH.: Collecting duct carcinoma: cytogenetic characterization. Histopathology 1992; 21: 155–160.

    Article  PubMed  Google Scholar 

  117. Selli C, Amorosi A, Vona G, Sestini R, Travaglini F, Bartoletti F, Orlando C.: Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. J. Urol. 1997; 158: 245–247.

    Article  PubMed  CAS  Google Scholar 

  118. Davis CJ, Mostofi FK, Sesterhenn IA.: Renal medullary carcinoma the seventh sickle cell nephropaty. Am. J. Surg. Pathol. 1995; 19: 1–11.

    Article  PubMed  Google Scholar 

  119. Dimashkieh H, Choe J, Mutema G.: Renal medullary carcinoma. A report of 2 cases and review of the literature. Arch. Pathol. Lab. Med. 2003; 127: 135–138.

    Google Scholar 

  120. Swartz MA, Karth J, Schneider DT, Rodrìguez R, Beckwith JB, Perlman EJ.: Renal medullary carcinoma, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 2002; 60: 1083–1089

    Article  PubMed  Google Scholar 

  121. Rodriguez-Jurado R, Gonzàlez-Crussi F.: Renal medullary carcinoma. Immunohistochemical and ultrastructural observations. J. Urol. Pathol. 1996; 4: 191–203.

    Google Scholar 

  122. Avery RA, Harris JE, Davis CJ Jr, Borgaonkar DS, Byrd JC, Weiss RB.: Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer 1996; 78: 128–132.

    Article  PubMed  CAS  Google Scholar 

  123. Polascik TJ, Bostwick DG, Cairos P.: Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 2002; 60: 941–946.

    Article  PubMed  Google Scholar 

  124. Yip D, Steer C, al-Nawab M, van der Walt J, Harper P.: Collecting duct carcinoma of the kidney associated with the sickle cell trait. Int. J. Clin. Pract. 2001; 55: 415–417.

    PubMed  CAS  Google Scholar 

  125. Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM, Vogelzang NJ, Teh BT.: Gene expression of profiling of renal medullary carcinoma: potential clinical relevance. Cancer 2004; 100: 976–985.

    Article  PubMed  Google Scholar 

  126. Hes O, Hora M, Perez-Montiel DM, Suster S, Curik R, Sokol L, Ondic O, Mikulastik J, Betlach J, Peychl K, Hrabal P, Kobec R, Struku L, Feràk I, Vrabec V, Michal M.: Spindle and cuboidal renal cell carcinoma, a tumor having frequent association with nephrolitiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/spindle and cuboidal renal cell carcinoma components. Histopathology 2002; 41: 549–555.

    Article  PubMed  CAS  Google Scholar 

  127. Weber A, Srigley J, Moch H.: Mucinous spindle cell carcinoma of the kidney. A molecular analysis. Pathologe 2003; 24: 453–459.

    Article  PubMed  CAS  Google Scholar 

  128. Rakozy C, Schmahl GE, Bogner S, Störkel S.: Low-grade tubular mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod. Pathol. 2002; 15:1162–1171.

    Article  PubMed  CAS  Google Scholar 

  129. Srigley JR.: Mucinous tubular and spindle cell carcinoma In Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 40. IARC Press, Lyon, 2004.

    Google Scholar 

  130. Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, Young A, Peralta-Venturina M, Amin MB.: Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue. Potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am. J. Surg. Pathol. 2005; 29: 747–754.

    Article  PubMed  Google Scholar 

  131. Ferlicot S, Allory Y, Comperat E, Mege-Lechevalier F, Dimet S, Sibony M, Couturier J, Vieillefond A.: Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature. Virchows Arch. 2005; 447: 978–983.

    Article  PubMed  Google Scholar 

  132. Parwani AV, Husain AN, Epstein JI, Beckwith JB, Argani P.: Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum. Pathol. 2001; 32: 506–512.

    Article  PubMed  CAS  Google Scholar 

  133. Argani P, Ladanyil M.: Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 37. IARC Press, Lyon, 2004.

    Google Scholar 

  134. Argani P, Antonescu CR, Couturier J, Fournet JC, Sciot R, Debiec-Rychter M, Hutchinson B, Reuter VE, Boccon-Gibod L, Timmons C, Hafez N, Ladanyi M.: PRCC-TFE3 renal carcinomas. Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am. J. Surg. Pathol. 2002; 26: 1553–1566.

    Article  PubMed  Google Scholar 

  135. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M.: Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. A sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 2003; 27: 750–761.

    Article  PubMed  Google Scholar 

  136. Imbert MC, Gerard-Marchant R, Schwesguth O.: Tubulopapillary carcinoma of the kidney in children: apropos of 9 observations. Ann. Pediatr. (Paris) 1968; 15: 1094–1104.

    CAS  Google Scholar 

  137. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, Cooper CS.: The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum. Mol. Genet. 1996; 5: 1333–1338.

    Article  PubMed  CAS  Google Scholar 

  138. Bruder E, Passera O, Harms D, Leuschner I, Ladany M, Argani P, Eble JN, Struckmann K, Schraml P, Moch H.: Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 2004; 28: 1117–1132.

    Article  PubMed  Google Scholar 

  139. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E, Bridge J, Schuuring E, Schoenmakers EFPM, van Kessel AG.: Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum. Mol. Genet. 2003; 12: 1661–1669.

    Article  PubMed  CAS  Google Scholar 

  140. Zisman A, Chao DH, Pantuck AJ, Kim HJ, Wieder JA, Figlin RA, Said JW, Belldegrun AS.: Unclassified renal cell carcinoma: clinical features and prognostic impact of new histological subtypes. J. Urol. 2002; 168: 950–955.

    Article  PubMed  Google Scholar 

  141. Dijkhuizen T, Van Den Berg E, Van Den Berg A, Van De Veen A, Dam A, Faber H, Buys CH, Storkel S, De Jong B.: Genetics as a diagnostic tool in sarcomatoid renal cell cancer. Int. J. Cancer 1997; 72: 265–269.

    Article  PubMed  CAS  Google Scholar 

  142. Shannon B, Wisniewski ZS, Bentel J, Cohen RJ.: Adult rhabdoid renal cell carcinoma. Divergent differentiation of conventional (clear cell) carcinoma. Arch. Pathol. Lab. Med. 2002; 126: 1506–1510.

    PubMed  Google Scholar 

  143. Shannon BA, Cohen RJ.: Rhabdoid differentiation of chromophobe renal cell carcinoma. Pathology 2003; 35: 228–230.

    Article  PubMed  Google Scholar 

  144. Gokden N, Nappi O, Swanson PE, Pfeifer JD, Vollmer RT, Wick MR, Humphrey PA.: Renal cell carcinoma with rabdoid features. Am. J. Surg. Pathol. 2000; 24: 1329–1338.

    Article  PubMed  CAS  Google Scholar 

  145. Tickoo SK, Reuter VE, Amin MB, Srigley JR, Epstein JI, Min KW, Rubin MA, Ro JY.: Renal oncocytosis. A morphologic study of fourteen cases. Am. J. Surg. Pathol. 1999; 23: 1094–1101.

    Article  PubMed  CAS  Google Scholar 

  146. Pavlovich CP, Walter MM, Eyler RA, Hewitt SM, Zbar B, Linehan WM, Merino MJ.: Renal tumors in the Birt-Hogg-Dube syndrome. Am. J. Surg. Pathol. 2002; 26: 1542–1552.

    Article  PubMed  Google Scholar 

  147. Lindgren V, Paner GP, Flanigan RC, Clark JI, Campbell SC, Picken MM.: Renal tumor with overlapping distal nephron morphology and karyotype. Arch. Pathol. Lab. Med. 2004; 128: 1274–1278.

    PubMed  Google Scholar 

  148. Gong Y, Sun X, Haines GK, Pins MR.: Renal cell carcinoma, chromophobe type, with collecting duct carcinoma and sarcomatoid components. Arch. Pathol. Lab. Med. 2003; 127: 38–40.

    Google Scholar 

  149. Matei DV, Rocco B, Varela R, Verwei F, Scardino E, Renne G, De Cobelli O.: Synchronous collecting duct carcinoma and papillary renal cell carcinoma: A case report and review of the literature. Anticancer Res. 2005; 25: 579–586.

    PubMed  Google Scholar 

  150. Amin MB, Michal M, Radhakrishnan A, Hes O, McKenney JK, Cheville JC.: Primary thyroid-like follicular carcinoma of the kidney: A histological distinctive primary renal epithelial tumor. Mod. Pathol. 2004; 17 (S1): 136A (A 567).

    Google Scholar 

  151. Farah R, Ben-Izhak O, Munichor M, Cohen H.: Low-grade renal collecting duct carcinoma. A case report with histochemical, immunohistochemical, and ultrastructural study. Ann. Diagn. Pathol. 2005; 9: 46–48.

    Article  PubMed  Google Scholar 

  152. MacLennan GT, Farrow GM, Bostwick DG.: Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology 1997; 50: 679–684.

    Article  PubMed  CAS  Google Scholar 

  153. Renshaw AA, Granter SR, Fletcher JA, Kozakewick HP, Corless CL, Perez-Atayde AR.: Renal cell carcinomas in children and young adults. Increased incidence of papillary architecture and unique subtypes. Am. J. Surg. Pathol. 1999; 23: 795–802.

    Google Scholar 

  154. Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, Zincke H, Blute ML.: Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J. Urol. 2005; 173: 1893–1896.

    Article  PubMed  Google Scholar 

  155. Medeiros LJ.: Renal cell carcinoma associated with neuroblastoma. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 39. IARC Press, Lyon, 2004.

    Google Scholar 

  156. Presti JC Jr, Moch H, Gelb AB, Huynth D, Wadman FM.: Initiating genetic events in small renal neoplasms detected by comparative genomic hybridization. J. Urol. 1998; 160: 1557–1561.

    Article  PubMed  Google Scholar 

  157. Merino MJ, Eccles DM, Linehan WM, Algaba F, Zbar B, Kovacs G, Kleihues P, Geurts van Kessel A, Kiuru M, Launonen V, Herva R, Aaltonen LA, Neumann HPH, Pavlovich CP.: Familial renal cell carcinoma. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. p. 15. IARC Press, Lyon, 2004.

    Google Scholar 

  158. Maher ER, Kaelin WG.: von Hippel-Lindau disease. Medicine 1997; 76: 381–391.

    Article  PubMed  CAS  Google Scholar 

  159. Prat E, Bernues M, Del Rey J, Camps J, Ponsa I, Algaba F, Egozcue J, Caballin MR, Gelabert A, Miro R.: Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma. Cancer Genet. Cytogenet. 2006; 15; 142–147.

    Google Scholar 

  160. Sampson JR, Patel A, Mee AD.: Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family. J. Med. Genet. 1995; 32: 848–850.

    PubMed  CAS  Google Scholar 

  161. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA.: Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc. Natl. Acad. Sci. USA. 2001; 13: 3387–3392.

    Article  Google Scholar 

  162. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM.: Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J. Clin. Endocrinol. Metab. 2000; 85: 1758–1764.

    Article  PubMed  CAS  Google Scholar 

  163. Weirich G, Glenn G, Junker K, Merino M, Storkel S, Lubensky I, Choyke P, Pack S, Amin M, Walther MM, Linehan WM, Zbar B.: Familial renal oncocytoma: clinicopathological study of 5 families. J. Urol. 1998; 160: 335–340.

    Article  PubMed  CAS  Google Scholar 

  164. 164. Algaba F.: Modern molecular classification of renal cell carcinoma: relevance for urologists. In Progress and Controversies in Oncological Urology VII (PACIOU VII), edited by Bangma ChH, Newling DWW. pp. 286–290. The Parthenon Publising Group, London, 2003.

    Google Scholar 

  165. Schraml P, Muller D, Bednar R, Gasser T, Sauter G, Mihatsch MJ, Moch H.: Allelic loss: the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma. J. Pathol. 2000; 190: 457–461.

    Article  PubMed  CAS  Google Scholar 

  166. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G.: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am. J. Pathol. 1999; 154: 981–986.

    PubMed  CAS  Google Scholar 

  167. Shi T, Seligson D, Belldegrun AS, Palotie A, Horvath S.: Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma. Mod. Pathol. 2005; 18: 547–557.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Ferran Algaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yolanda Arce
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isabel Trias
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Academic Medical Center University Hospital, Amsterdam, The Netherlands

    Jean J.M.C.H. de la Rosette MD,PhD (Chairman) (Chairman)

  2. Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy

    Cora N. Sternberg MD,FACP (Chairman) (Chairman)

  3. Department of Urology, University Hospital of Katholieke Universiteit Leuven, Leuven, Belgium

    Hein P.A. van Poppel MD,PhD (Chairman) (Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Algaba, F., Arce, Y., Trias, I. (2008). Pathology of Renal Cell Carcinoma: Correlation of Morphology, Immunophenotype, and Genetic and Clinical Aspects. In: Rosette, J.J.d., Sternberg, C.N., Poppel, H.P.v. (eds) Renal Cell Cancer. Springer, London. https://doi.org/10.1007/978-1-84628-763-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-763-3_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-385-7

  • Online ISBN: 978-1-84628-763-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation